Skip to content

Research on the Mechanism and Clinical Application of different Orthokeratology Lenses in Regulating Children's Visual Function and Myopia Control

Clinical Study on the Effectiveness of Different Orthokeratology Lenses in Controlling Myopia Progression in Children and Adolescents

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113706
Enrollment
Unknown
Registered
2025-12-02
Start date
2022-08-05
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Experimental group:Specialty-designed Orthokeratology Lens Group are precision-customized by incorporating adjustments to the Base Curve (BC). The daily wearing duration at night exceeds 8 hours.
Control group:Regular Orthokeratology Lens Group: The daily wearing duration at night exceeds 8 hours.

Sponsors

Shanghai Eye Disease Prevention and Treatment Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Patients with binocular myopia within -1.00D to -3.00D and astigmatism within -1.50D, who need orthokeratology lens fitting and voluntarily participate with informed consent signed by themselves or their legal guardians. 2. Patients whose visual acuity can reach 1.0 or above when corrected by frame glasses. 3. Patients with corneal curvature between 40.00D and 46.00D. 4. Patients not using medications that affect or may affect orthokeratology lens wearing and may alter normal ocular physiology. 5. Patients whose environmental, hygienic, and working conditions can meet the wearing requirements of orthokeratology lenses. 6. Patients with good compliance who can timely and regularly visit medical institutions as required.

Exclusion criteria

Exclusion criteria: 1. Patients under 8 years of age. 2. Use of medications that affect or may affect the wearing of orthokeratology lenses and may alter normal ocular physiology. 3. Patients who do not meet the inclusion criteria. 4. Active corneal infection or other acute/chronic anterior segment inflammations. 5. Use of medications that may cause dry eye or affect vision and corneal curvature, etc. 6. Corneal endothelial cell density less than 2,000 cells/mm². 7. Corneal abnormalities; obvious corneal epithelial fluorescence staining; history of corneal surgery or trauma; active keratitis (e.g., corneal infection), decreased corneal sensation. 8. Other ocular diseases: such as dacryocystitis, eyelid diseases and abnormalities, abnormal intraocular pressure, glaucoma, etc. 9. Systemic diseases causing immunodeficiency or affecting orthokeratology (e.g., acute/chronic sinusitis, diabetes, Down syndrome, rheumatoid arthritis, psychiatric disorders, etc.). 10. History of allergy to contact lenses or contact lens care solutions. 11. Pregnant women, lactating women, or those planning to become pregnant in the near future. 12. Patients deemed ineligible by the investigator.

Design outcomes

Primary

MeasureTime frame
Axial length;

Countries

China

Contacts

Public ContactZhujianfeng

Shanghai Eye Disease Prevention and Treatment Center

jfzhu1974@qq.com+86 135 0182 2932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026